INS and obesity due to melanocortin 4 receptor deficiency: Although insulin has long been thought to be a critical mediator of obesity-driven cancer, in vivo evidence for a role in early tumor development in faithful cancer models has only recently emerged (Wang et al, 2018; Zhang et al, 2019).